The Integrated BioBank of Luxembourg (IBBL) is an independent, not-for-profit biobanking and biotechnology foundation designed to facilitate new, high quality medical research in Luxembourg and to bring the next generation of healthcare to its citizens. The IBBL collects, stores, and analyses biological samples and associated data, which are then made available to research organizations investigating new treatments for diseases. Biobanks like the IBBL play a critical role in modern medical research by allowing researchers to improve our understanding of diseases and identify suitable treatments.
The IBBL has built an integrated and solid infrastructure to support a successful biomedical research industry in Luxembourg and facilitate rapid translation of discoveries into improved care:
* A Biospecimen Collection and Biorepository that contains high quality tissues and maintains strong quality control of the specimens and the clinical data associated with the tissue samples, while maintaining the highest biobanking ethical standards.
* A Biorefinery Analysis and Research service that can make high quality analytes from tissues (e.g. DNA, RNA and protein), maintains technology for high throughput gene sequencing and gene expression, and conducts biospecimen research.
* An Informatics Platform to maintain the clinical and biospecimens data in a secure fashion to guarantee the privacy of individual data and to provide data to the bioinformatics hub at the Luxembourg Centre for Systems Biomedicine (LCSB) for additional analysis.
The IBBL supports the Luxembourg Personalized Medicine Consortium (PMC) and its partners by collecting, storing and redistributing biospecimens and their related clinical data, which are suitable for analyses by state-of-the-art genomics and proteomics platforms used in personalized medicine research. The IBBL works closely with the research teams of the PMC's four major research programs in personalized medicine (cancer, type 2 diabetes, Parkinson's Disease and normal population cohort) by providing them with biospecimens and clinical data and by analyzing biospecimens using sophisticated molecular analyses that are not feasible in individual research laboratories.
Samples are collected by IBBL personnel from hospitals in a targeted manner, principally to support priority research projects, but potentially for other research. This targeted sampling based on the needs of the medical community ensures that each sample provides the highest scientific value for those investigating diagnoses, causes, prevention and the successful treatment of disease.
The IBBL collaborates with leading research and health organizations in North America, Europe and the Middle East, and with the major international biobanking societies.
Resource Type: Resource
Version: Latest Version
clinical data, tissue, dna, rna, protein, lymphoblastoid cell line, frozen, liquid nitrogen, formalin-fixed paraffin-embedded, histology slide, tissue microarray, cancer, type 2 diabetes, parkinson's disease, normal
Additional Resource Types
biomaterial supply resource, tissue bank, material storage repository, biomaterial analysis service, data or information resource
Includes: Cancer, Type 2 diabetes, Parkinson's disease, Normal
Last checked up;
One Mind Biospecimen Bank Listing, European Biobank
Frozen, Liquid nitrogen, Formalin-fixed paraffin-embedded, Histology slide, Tissue microarray
Sample type: Tissue, DNA, RNA, Protein, Lymphoblastoid cell line
Public / Collaborators: The IBBL collaborates with leading research and health organizations in North
America, Europe and the Middle East, and with the major international biobanking
Created 4 years ago by Anonymous